why choose us

First received: June 16, 2023

Clinical Trial: Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: Association of Genetic Variations and Weight Loss Response to Naltrexone/Bupropion

Brief Summary: The goal of this clinical trial is to understand if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss.The main question[s] it aims to answer are:In Aim One, the investigators propose to rigorously test the hypothesis that presence of the Taq1A A1+ polymorphism is associated with greater weight loss with NB compared with the A1- genotype.In Aim Two, the investigators will explore other genetic polymorphisms that might influence the…

Read more